Leiv Lea - Net Worth and Insider Trading
Leiv Lea Net Worth
The estimated net worth of Leiv Lea is at least $579,010 dollars as of 2024-06-06. Leiv Lea is the CFO of Corvus Pharmaceuticals Inc and owns about 282,444 shares of Corvus Pharmaceuticals Inc (CRVS) stock worth over $579,010. Details can be seen in Leiv Lea's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Leiv Lea has not made any transactions after 2022-12-14 and currently still holds the listed stock(s).
Transaction Summary of Leiv Lea
Leiv Lea Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Leiv Lea owns 1 companies in total, including Corvus Pharmaceuticals Inc (CRVS) .
Click here to see the complete history of Leiv Lea’s form 4 insider trades.
Insider Ownership Summary of Leiv Lea
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRVS | Corvus Pharmaceuticals Inc | 2022-12-14 | Chief Financial Officer |
Leiv Lea Latest Holdings Summary
Leiv Lea currently owns a total of 1 stock. Leiv Lea owns 282,444 shares of Corvus Pharmaceuticals Inc (CRVS) as of December 14, 2022, with a value of $579,010.
Latest Holdings of Leiv Lea
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRVS | Corvus Pharmaceuticals Inc | 2022-12-14 | 282,444 | 2.05 | 579,010 |
Holding Weightings of Leiv Lea
Leiv Lea Form 4 Trading Tracker
According to the SEC Form 4 filings, Leiv Lea has made a total of 2 transactions in Corvus Pharmaceuticals Inc (CRVS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Corvus Pharmaceuticals Inc is the acquisition of 34,000 shares on December 14, 2022, which cost Leiv Lea around $25,500.
Insider Trading History of Leiv Lea
- 1
Leiv Lea Trading Performance
GuruFocus tracks the stock performance after each of Leiv Lea's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Leiv Lea is -8.89%. GuruFocus also compares Leiv Lea's trading performance to market benchmark return within the same time period. The performance of stocks bought by Leiv Lea within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Leiv Lea's insider trading performs compared to the benchmark.
Performance of Leiv Lea
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 31.28 | | | | | |
| Relative Return to S&P 500(%) | 30.04 | | | | | |
Leiv Lea Ownership Network
Leiv Lea Owned Company Details
What does Corvus Pharmaceuticals Inc do?
Who are the key executives at Corvus Pharmaceuticals Inc?
Leiv Lea is the Chief Financial Officer of Corvus Pharmaceuticals Inc. Other key executives at Corvus Pharmaceuticals Inc include director & President and CEO Miller Richard A Md , See Remarks William Benton Jones , and 10 percent owner Ecor1 Capital, Llc .
Corvus Pharmaceuticals Inc (CRVS) Insider Trades Summary
Over the past 18 months, Leiv Lea made 1 insider transaction in Corvus Pharmaceuticals Inc (CRVS) with a net purchase of 34,000. Other recent insider transactions involving Corvus Pharmaceuticals Inc (CRVS) include a net purchase of 637,634 shares made by Miller Richard A Md , a net purchase of 40,000 shares made by William Benton Jones , and a net purchase of 10,000 shares made by Linda S Grais .
In summary, during the past 3 months, insiders sold 0 shares of Corvus Pharmaceuticals Inc (CRVS) in total and bought 597,634 shares, with a net purchase of 597,634 shares. During the past 18 months, 0 shares of Corvus Pharmaceuticals Inc (CRVS) were sold and 721,634 shares were bought by its insiders, resulting in a net purchase of 721,634 shares.
Corvus Pharmaceuticals Inc (CRVS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Corvus Pharmaceuticals Inc Insider Transactions
Leiv Lea Mailing Address
Above is the net worth, insider trading, and ownership report for Leiv Lea. You might contact Leiv Lea via mailing address: Pharmacyclics Inc, 995 E Arques Ave, Sunnyvale Ca 94085-4521.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
